John K. Scott Jr. - Nov 15, 2021 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB)

Role
Director, 10%+ Owner
Signature
/s/ Erika L. Eves for John K. Scott, Jr. by power of attorney
Stock symbol
NAVB
Transactions as of
Nov 15, 2021
Transactions value $
$30
Form type
4
Date filed
12/2/2021, 03:13 PM
Next filing
Jan 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAVB Common Stock Award $30.00 +30K +0.37% $0.00* 8.08M Nov 15, 2021 Direct F1
transaction NAVB Common Stock Award $0 +2.48K +0.03% $0.00 8.08M Nov 15, 2021 Direct F2, F4
transaction NAVB Common Stock Award $0 +1.25K +0.02% $0.00 8.08M Nov 30, 2021 Direct F3, F4
holding NAVB Common Stock 10.1K Nov 15, 2021 By spouse and children F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted shares granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan which vest as to one-third on each of the first three anniversaries of the date of grant.
F2 Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of quarterly non-employee director fees.
F3 Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of monthly non-employee director fees.
F4 Issuance deferred at the request of the Reporting Person.
F5 Includes 2,639 shares of Common Stock owned by the Reporting Person's spouse and 7,500 shares of Common Stock owned by the Reporting Person's children. The Reporting Person may be deemed to have shared voting and/or dispositive power with respect to such shares.